Pukang Bio is a professional manufacturer of long-acting peptide, Small Molecule Compounds, API and Advanced Excipients, LINKERs, PEGs.

Long-acting side chains can be used for GLP-1, GCP and anti-HIV drugs to improve half-life and enhance patient compliance.

Pukang Biological has built a peptide long-acting drug platform, which can not only provide hundreds of different types of peptide long-acting side chain molecules, but also provide high-quality long-acting side chain design services, quality research and CDE documents.

We are here to provide you long-acting peptide, Small Molecule Compounds, API and Advanced Excipients, LINKERs, PEGs at the best price.

PRODUCTS

Professionally provide high quality Polypeptide Modified Side Chains , Small Molecule Compounds and Advanced Excipients, LINKERs, PEGs

01

PEGS

02

Long-acting Polyeptide Modified Side Chain

03

Small Molecule

Compounds

04

Advanced excipients

05

Linkers

06

RNAi

01

PEGS

02

Long-acting Peptide Drug Platform

03

Small Molecule

Compounds

04

API and Advanced excipients

05

Linkers

06

RNAi

Our company is the first Shanghai-based innovator that has been producing and developing long-acting peptide products. With the leading technology and manufacturing capabilities, we have built a platform for producing long-acting peptide drugs, becoming one of the largest suppliers in China.

ABOUT PUKANG

Chengdu Pukang Biotechnology Co., Ltd was founded in 2008 and it is located in the national cross-strait science and technology industry development park——Cross-Strait Science and Technology Park,Wenjiang District,Chengdu,specializing in the research & development of polypeptide modifiers. As a manufacturer, it integrates production, sales, research and development. At present, our company has a R&D center of 2400 square meters, and a production workshop of 1000 square meters.

More About Pukang

Founded

R & D Center

Production workshop

Production base

TECHNOLOGY

Chengdu Pukang is a professional manufacturer of long-acting Polypeptide Modifiers, Small Molecule Compounds,and Advanced Excipients, LINKERs, PEGs.

We can provide not only a large number of different types of long-acting side chains, but also extensive product development services, including high quality designs, technical consultation, and characterization reports.

GOOD QUALITY，GOOD TECHNOLOGY .

Chengdu Pukang has a professional R&D team with rich experience, and innovative ideas, which can meet the various needs of customers from custom synthesis to mass production. Pukang has sufficient resources to provide process development, optimization and scale-up production. The R & D will cooperate with the production to solve the problems encountered in the pilot scale up process. We are more professional, more efficient to provide customers with high quality products.

Acquire More

BUILT FOR LIFE AND HEALTH

——————————————————————————

Polyethylene glycols is used in a wide range of biomedical applications including drug delivery, ADC conjugation, fluorescent labeling & targeted diagnostics, oligonucleotides bioconjugation, surface modification and PEGylation of protein &peptide.

NEWS

Latest technology learnings and upcoming events of Pukang

Peptide Half-Life Extension I: Fatty-Acid Acylation and Albumin Binding

封面：标题：Peptide Half-Life Extension I: Fatty-Acid Acylation and Albumin BindingWhy lipidation became a clinically validated strategy for longer-acting peptide medicinesWhat does lipidation actually change?Fatty-acid acylation is often described as a simple conjugation step: attach a lipid chain to a

Beyond Half-Life: Six Routes to Longer-Acting Peptide Therapeutics

封面图：Beyond Half-Life: Six Routes to Longer-Acting Peptide Therapeutics Extending the half-life of a peptide is not always the same as extending its therapeutic value. The more relevant development goal is to create an exposure profile that supports the intended pharmacology, dosing interval, and the

Sichuan Pukang Pharmaceutical Phase II Facility Commissioned, Expanding Manufacturing Capacity for Long-Acting Peptide Raw Materials

Sichuan Pukang Pharmaceutical Phase II Facility Commissioned, Expanding Manufacturing Capacity for Long-Acting Peptide Raw Materials On May 15, 2026, the Phase II facility of Sichuan Pukang Pharmaceutical was officially completed and commissioned. Figure 1: Completion Ceremony for Phase II of Sichua

SERVICES

Pukang provides you with pharmaceutical services

Pukang can provide one-stop service from customer order to delivery, including the feedback of production progress, various items testing and technical documents support.